| Product dosage: 150mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.01 | $40.07 (0%) | 🛒 Add to cart |
| 20 | $3.01 | $80.14 $60.10 (25%) | 🛒 Add to cart |
| 30 | $2.34 | $120.21 $70.12 (42%) | 🛒 Add to cart |
| 60 | $1.34 | $240.42 $80.14 (67%) | 🛒 Add to cart |
| 90 | $1.00 | $360.62 $90.16 (75%) | 🛒 Add to cart |
| 120 | $0.83 | $480.83 $100.17 (79%) | 🛒 Add to cart |
| 180 | $0.75 | $721.25 $135.23 (81%) | 🛒 Add to cart |
| 270 | $0.67 | $1081.87 $180.31 (83%) | 🛒 Add to cart |
| 360 | $0.58
Best per pill | $1442.50 $210.36 (85%) | 🛒 Add to cart |
Similar products
More info:
zyban
Zyban, known generically as bupropion hydrochloride, is a prescription medication primarily indicated as an aid to smoking cessation. It functions as an atypical antidepressant and norepinephrine-dopamine reuptake inhibitor (NDRI), distinct from SSRIs, which has made it a valuable tool in addiction medicine. Originally developed and investigated as an antidepressant, its utility in helping people quit smoking was discovered somewhat serendipitously during clinical trials, where participants reported a reduced desire to smoke.
bupron sr
Bupropion SR, or sustained-release bupropion, represents one of those rare psychopharmacological innovations that actually changed how we approach depression treatment in clinical practice. Unlike the flood of me-too SSRIs that dominated the 90s, bupropion SR brought something genuinely different to the table - a novel mechanism targeting norepinephrine and dopamine without the serotonergic activity that caused so many side effects for our patients. I remember when we first started using it at our clinic, we were frankly skeptical about yet another antidepressant claim, but the distinct profile quickly won over even our most conservative prescribers.
bupropion
Bupropion represents one of the more fascinating psychotropic agents in our modern arsenal—an atypical antidepressant that defies easy classification. Unlike the SSRIs that dominated the 1990s, bupropion operates through a completely different pathway, acting primarily as a norepinephrine-dopamine reuptake inhibitor (NDRI) with minimal serotonergic activity. This unique mechanism not only explains its distinct side effect profile but also its expanding off-label applications beyond major depressive disorder. I remember when we first started using it more regularly in our practice back in the early 2000s—we had this 42-year-old patient, Mark, who had failed two previous SSRI trials due to sexual side effects and weight gain.
Champix: Effective Smoking Cessation Aid - Evidence-Based Review
Champix, known generically as varenicline, is a prescription medication specifically developed as a smoking cessation aid. It functions as a partial agonist on nicotinic acetylcholine receptors, essentially tricking the brain into thinking it has received nicotine, which reduces both withdrawal symptoms and the pleasure derived from smoking if a person does slip up and have a cigarette. It’s a cornerstone in the pharmacological approach to tackling nicotine addiction, representing a significant advancement over previous options like nicotine replacement therapy (NRT) or bupropion.
wellbutrin
Bupropion hydrochloride, marketed under the brand name Wellbutrin among others, represents a unique chemical entity in the antidepressant pharmacopeia. Unlike the more common selective serotonin reuptake inhibitors (SSRIs), this compound belongs to the aminoketone class and functions primarily as a norepinephrine-dopamine reuptake inhibitor (NDRI). What’s fascinating from a clinical perspective is how this distinct mechanism translates to a different side effect profile—particularly the notable absence of sexual dysfunction that plagues so many other antidepressants.
wellbutrin sr
Bupropion hydrochloride sustained-release tablets - we’re talking about one of the most pharmacologically interesting antidepressants in our arsenal. Unlike the SSRIs that dominate first-line treatment, this compound brings a completely different mechanism to the table, acting primarily as a norepinephrine-dopamine reuptake inhibitor with minimal serotonergic activity. The SR formulation specifically provides that controlled release over 12 hours, which honestly makes a world of difference in terms of side effect profile and patient adherence compared to the immediate-release version.
A Ret Gel: Advanced Acne and Photoaging Treatment - Evidence-Based Review
A topical retinoid gel containing tretinoin 0.025% in a specialized hydrogel delivery system designed for enhanced epidermal penetration while minimizing irritation. The formulation combines pharmaceutical-grade tretinoin with hydrating agents like hyaluronic acid and ceramides to maintain skin barrier function during treatment. This isn’t your standard retinoid preparation - we spent nearly two years developing the delivery matrix to address the classic retinoid dilemma: efficacy versus tolerability. 1. Introduction: What is A Ret Gel?
Abana: Comprehensive Cardiovascular Support Through Herbal Synergy - Evidence-Based Review
Product Description: Abana represents one of those formulations that initially made me skeptical - another herbal blend claiming cardiovascular benefits. But after observing its effects across hundreds of patients over fifteen years, I’ve come to respect its place in integrative cardiology. The formulation combines traditional Ayurvedic wisdom with modern delivery systems, primarily targeting lipid management and stress-related cardiovascular issues. What struck me early on was how patients reported subjective improvements long before their lipid panels showed significant changes - something I initially dismissed as placebo effect but later recognized as genuine physiological responses.
Abhigra: Advanced Gut Barrier Support for Chronic Inflammatory Conditions - Evidence-Based Review
Before we dive into the formal monograph, let me give you the real story behind Abhigra. We spent three years developing this formulation after noticing something strange in our inflammatory bowel disease clinic – patients taking certain traditional preparations had significantly lower CRP levels than expected. The initial prototype failed miserably in our first pilot study – bioavailability was practically nonexistent. Our pharmacologist wanted to abandon the whole project, but our lead clinician insisted we try a different delivery system.